Telix Pharmaceuticals Limited (TLX) is a global biopharmaceutical company engaged in the development and commercialization of targeted therapeutic and diagnostic radiopharmaceuticals, along with supporting medical technologies. Headquartered in Melbourne, Australia, Telix maintains strategic international operations across the United States, Brazil, Canada, Europe (Belgium and Switzerland), and Japan.
Find out what a historical investment in Telix Pharmaceuticals Limited would be worth today using our TLX stock calculator.
Buying TLX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Telix Pharmaceuticals Limited in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in TLX
What is the ticker symbol of Telix Pharmaceuticals Limited?
The ticker symbol for Telix Pharmaceuticals Limited is TLX.
How much is one share of TLX?
One share of TLX is valued at $12.92 as of 21 November 2026.
What is the market capitalisation of Telix Pharmaceuticals Limited TLX?
As of 21 November 2026 Telix Pharmaceuticals Limited has a market cap of $4.39B.
What is the P/E ratio of TLX?
The Price to Earnings ratio of TLX is -419.68.
What is the Earnings Per Share of TLX?
The Earnings Per Share of TLX is -$0.03.
What is the 52-week high for Telix Pharmaceuticals Limited stock?
The Telix Pharmaceuticals Limited 52-week high stock price is $18.22.
What is the 52-week low for Telix Pharmaceuticals Limited stock?
The Telix Pharmaceuticals Limited 52-week low stock price is $8.26.
Can I buy TLX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TLX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.